Cargando…
Do Admitted COVID-19-Positive Patients on Anticoagulation Therapy Have a Reduced Hospital Stay and Disease Severity?
Background As of December 2021, the coronavirus disease 2019 (COVID-19) pandemic has resulted in the deaths of over 5 million people. It is known that infection with this virus causes a state of hypercoagulability. Because of this, there has been considerable debate on whether or not patients should...
Autores principales: | Nawaz, Haroon, Choudhry, Ayesha, Morse, William J, Zarnowski, Oskar, Patel, Harsh, Amin, Harshad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022187/ https://www.ncbi.nlm.nih.gov/pubmed/35475038 http://dx.doi.org/10.7759/cureus.23382 |
Ejemplares similares
-
Study of Demographic Profile, Etiology, and Clinical Outcome in Patients Admitted With Acute Encephalitis Syndrome From the Western Part of India
por: Roy, Dhara B, et al.
Publicado: (2022) -
Do Large Ears Have an Advantage in Preventing Airborne Transmission?
por: Kosaku, Komiya, et al.
Publicado: (2022) -
Impact of COVID-19 Infection on Quality of Sleep
por: Choudhry, Ayesha A, et al.
Publicado: (2021) -
Role of Anticoagulants for Stroke Prevention in Low-Risk Population Having Atrial Fibrillation and Chronic Kidney Disease: A Systematic Review
por: Ravi, Niriksha, et al.
Publicado: (2022) -
Electrolyte Imbalance at Admission Does Not Predict the Length of Stay or Mortality in Dengue-Infected Patients
por: Rehman, Fazal U, et al.
Publicado: (2020)